The aim of this ultrastructural study was to analyse quantitatively the distribution of gamma-aminobutyric acid (GABA)-like immunoreactivity in axon terminals apposed to somatic and proximal dendritic membranes of cat motoneurons in lumbar column 2. Preembedding immunocytochemistry was used to count the GABAergic terminals contacting profiles of eighteen alpha-and six gamma-motoneurons. Of the 1293 terminals counted on the somatic and proximal dendritic compartments of alpha-motoneurons, 197 were GABAergic. In contrast, a total number of only 62 terminals were counted on gamma-motoneurons, of which 8 were GABAergic. These populations of GABAergic terminals were less numerous than the population of glycinergic terminals observed in a previous study. The morphometric characteristics of GABAergic synapses were analyzed using postembedding immunocytochemistry. Most of the GABAergic terminals contained pleomorphic vesicles (F-type boutons, flattened or pleomorphic vesicles). All terminals presynaptic (P boutons) to large terminals containing sphericle vesicles (M-type boutons, characteristic of alpha-motoneurons), were GABA-immunopositive. These results suggest that there are different distributions of the GABAergic control of excitability on gamma- and alpha-motoneurons. GABA appears to be strongly involved in post-synaptic inhibition of alpha-motoneurons, whereas gamma-motoneurons receive very few GABAergic inhibitory inputs. Morphological correlates of GABAergic presynaptic inhibition were seen on alpha- but not on gamma-motoneurons.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0168-0102(95)00980-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Decoding Gene Networks Controlling Hypothalamic and Prethalamic Neuron Development.
bioRxiv
January 2025
Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Neuronal subtypes derived from the embryonic hypothalamus and prethalamus regulate many essential physiological processes, yet the gene regulatory networks controlling their development remain poorly understood. Using single-cell RNA- and ATAC-sequencing, we analyzed mouse hypothalamic and prethalamic development from embryonic day 11 to postnatal day 8, profiling 660,000 cells in total. This identified key transcriptional and chromatin dynamics driving regionalization, neurogenesis, and differentiation.
View Article and Find Full Text PDFSynaptic Targets and Cellular Sources of CB1 Cannabinoid Receptor and Vesicular Glutamate Transporter-3 Expressing Nerve Terminals in Relation to GABAergic Neurons in the Human Cerebral Cortex.
Eur J Neurosci
January 2025
Department of Pharmacology, University of Oxford, Oxford, UK.
Cannabinoid receptor 1 (CB1) regulates synaptic transmission through presynaptic receptors in nerve terminals, and its physiological roles are of clinical relevance. The cellular sources and synaptic targets of CB1-expressing terminals in the human cerebral cortex are undefined. We demonstrate a variable laminar pattern of CB1-immunoreactive axons and electron microscopically show that CB1-positive GABAergic terminals make type-2 synapses innervating dendritic shafts (69%), dendritic spines (20%) and somata (11%) in neocortical layers 2-3.
View Article and Find Full Text PDFUltrastructural Localization of Glutamate Delta Receptor 1 in the Rodent and Primate Lateral Habenula.
J Comp Neurol
January 2025
Graduate Program in Molecular and Systems Pharmacology, Emory University, Atlanta, Georgia, USA.
Glutamate delta receptor 1 (GluD1) is a unique synaptogenic molecule expressed at excitatory and inhibitory synapses. The lateral habenula (LHb), a subcortical structure that regulates negative reward prediction error and major monoaminergic systems, is enriched in GluD1. LHb dysfunction has been implicated in psychiatric disorders such as depression and schizophrenia, both of which are associated with GRID1, the gene that encodes GluD1.
View Article and Find Full Text PDFComparing adenosine A receptor modulation of cannabinoid CB receptor-mediated inhibition of GABA and glutamate release in rodent striatal nerve terminals.
Eur J Neurosci
January 2025
CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
In corticostriatal nerve terminals, glutamate release is stimulated by adenosine via A receptors (ARs) and simultaneously inhibited by endocannabinoids via CB receptors (CBRs). We previously identified presynaptic AR-CBR heterotetrameric complexes in corticostriatal nerve terminals. We now explored the possible functional interaction between ARs and CBRs in purified striatal GABAergic nerve terminals (synaptosomes) and compared these findings with those on the release of glutamate.
View Article and Find Full Text PDFMaternally activated connections of the ventral lateral septum reveal input from the posterior intralaminar thalamus.
Brain Struct Funct
January 2025
Department of Physiology and Neurobiology, Laboratory of Molecular and Systems Neurobiology, Eötvös Loránd University, Budapest, Hungary.
The lateral septum (LS) demonstrates activation in response to pup exposure in mothers, and its lesions eliminate maternal behaviors suggesting it is part of the maternal brain circuitry. This study shows that the density of pup-activated neurons in the ventral subdivision of the LS (LSv) is nearly equivalent to that in the medial preoptic area (MPOA), the major regulatory site of maternal behavior in rat dams. However, when somatosensory inputs including suckling were not allowed, pup-activation was markedly reduced in the LSv.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!